MURFREESBORO, TN / ACCESS Newswire / February 7, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that after more than 34 years of leadership and guidance on the NHI Board of ...

CLEVELAND, OH / ACCESS Newswire / February 7, 2025 / Dr. Airica Steed's legacy as the CEO of MetroHealth is one defined by progress, innovation, and an unwavering commitment to creating a more ...

SGD Pharma, a global market leader in pharmaceutical glass primary packaging solutions, has been recognized for its ...

The Plastic Surgery Instruments Market is poised for significant growth, with a projected market size of USD 2.68 Billion by ...

Researchers have created a remarkable new map of a key part of our brain, the hypothalamus, that will lead to new ways of ...

Palobiofarma Partners with Flex Databases for Advanced Pharmacovigilance ManagementFebruary 6, 2025Palobiofarma, a leading ...

BioMed X, a German independent research institute, announces the successful completion of its oncology research project in ...

Dr. Nicole Schrader provides customized solutions for eyelid asymmetry and excess skin through complex upper blepharoplasty ...

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.78% of subjects maintained a ...

Sanofi announced its intention to execute a share buyback program in 2025 of €5 billion, preferably through block trades and in the open market with the purpose of cancellation. A first tranche of ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a detailed analysis of its phase III REGENCY trial of Gazyva®/Gazyvaro® (obinutuzumab) in people with active lupus nephritis (LN) was published ...

Dermaliq Therapeutics, Inc. (Dermaliq) today announces that Ralf Paus, M.D., D.Sc., F.R.S.B. has joined the company’s Scientific and Medical Advisory Board.